Viewing StudyNCT03993964



Ignite Creation Date: 2024-05-06 @ 1:21 PM
Last Modification Date: 2024-10-26 @ 1:12 PM
Study NCT ID: NCT03993964
Status: UNKNOWN
Last Update Posted: 2019-06-21
First Post: 2019-06-13

Brief Title: Study to Evaluate the Efficacy and Safety of CDK46 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer
Sponsor: Sun Yat-sen University
Organization: Sun Yat-sen University

Organization Data

Organization: Sun Yat-sen University
Class: OTHER
Study ID: HR-BLTN-014
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Sun Yat-sen University
Lead Sponsor Class: OTHER
Responsible Party: wang shusen
Responsible Party Title: clinical professor
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Sun Yat-sen University
Old Name: None
Old Organization: None

Collaborators

Name Class
Jiangsu HengRui Medicine Co Ltd INDUSTRY